12:00 AM
 | 
Feb 02, 2015
 |  BC Week In Review  |  Company News  |  Deals

Applied Molecular Transport, J&J deal

Applied Molecular Transport granted Johnson & Johnson’s Janssen Biotech Inc. unit exclusive, worldwide rights to an undisclosed preclinical oral candidate, which is in development to treat...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >